Schonfeld Strategic Advisors LLC Biofrontera Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.4 - $0.65 $160 - $260	-400 Reduced 0.45%	88,500 $46,000
Q1 2023 May 15, 2023	SELL	$0.56 - $1.02 $1,568 - $2,856	-2,800 Reduced 3.05%	88,900 $54,000
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.05 $308 - $420	400 Added 0.44%	91,700 $84,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.26 $491 - $756	-600 Reduced 0.65%	91,300 $96,000
Q2 2022 Aug 15, 2022	BUY	N/A	2,600 Added 2.91%	91,900 $171,000

Q1 2022 May 16, 2022	BUY	N/A	89,300 New	89,300 $298,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $19.8M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.